Growing prevalence of acute kidney injury as well as increasing early diagnosis with subsequent increasing treatment seeking rate are the prime drivers of the global acute kidney injury treatment market. Treatment such as dialysis therapies has resulted in better management of acute kidney injury, and has helped reduce the risk of various kidney-related diseases. Various organizations are involved in acute kidney injury disease surveillance. In 2017, China’s central government issued the 13th Five Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data, develop technologies for precision medicine, and integrate them into a multilevel knowledge database, leading the healthcare treatment market to new growth avenues.
ACUTE KIDNEY INJURY TREATMENT MARKET TAXONOMY
The global acute kidney injury treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.
Product
- Dialysis
- Intermittent Hemodialysis
- Continuous Renal Replacement Therapy (CRRT)
- Sustained Low Efficiency Dialysis (SLED)
- Drug Therapy
- Antibiotics
- Diuretics
- Immunosuppressive Agents
Injury
- Pre-renal Injury
- Intrinsic Renal Injury
- Post-renal Injury
Distribution Channel
- Hospitals
- Ambulatory Surgical Centers
- Others
Region
- North America
- LATAM
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-9399
Owing to increasing acute kidney injury prevalence, number of dialysis centers, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
The intermittent hemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
Advancements in diagnostic technology and more product availability in order to streamline their product offerings in respective regions with diverse product portfolios are being followed by players in the acute kidney injury treatment market. For instance, in January, 2019, Fresenius Medical Care launched the 4008A dialysis machine to improve accessibility to life-sustaining dialysis treatment.
Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each segment from 2014 to 2029. The global acute kidney injury treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers. The study provide compelling insights on the acute kidney injury treatment market on the basis of product (dialysis and drug therapy), injury (pre-renal injury, intrinsic renal injury, and post-renal injury), and distribution channel (hospitals, ambulatory surgical centers, and others), across seven major regions.